Author:
Friedmacher Florian,Puri Prem
Publisher
Springer Berlin Heidelberg
Reference56 articles.
1. Al Hindi S, Mubarak M, Al AH. High-grade vesicoureteral reflux in infants: Our experience with endoscopicsubureteric injections. Urologia. 2022;89(1):120–5.
2. Baybikov R, Sizonov V, Bondarenko S, Dolgov B, Dubrov V, Kagantsov I, et al. Do the type of bulking agents and injection method have any influence on the incidence of ureteral obstruction by endoscopic treatment of reflux? J Pediatr Urol. 2015;11(Suppl 4)
3. Ben-Meir D, Morgenstern S, Sivan B, Efrat R, Livne PM. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux. J Urol. 2012;188(1):258–61.
4. Ben-Meir D, Bahouth Z, Halachmi S. Late-onset Uretero-vesical Junction Obstruction Following Endoscopic Injection of Bulking Material for the Treatment of Vesico-ureteral Reflux. Urology. 2017;101:60–2.
5. Benoit RM, Peele PB, Docimo SG. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 1: substitution for surgical management. J Urol. 2006;176(4 Pt 1):1588–92.